AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
—·9d
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
TickersAIChannelsstocksCountriesusaCategoriesceo-changes
Open original source ↗Published
6/5/2026, 10:26:16 PM
Fetched
6/6/2026, 12:07:29 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
en